Iconix Pharmaceuticals, Inc.

Iconix Pharmaceuticals Inc. is pioneering the new field of chemogenomics, the integration of chemistry and genomics to profile drug candidates. Iconix’s chemogenomic capabilities enable pharmaceutical companies to increase the odds of advancing the right compounds to the clinic, reducing attrition rates and the costs of drug discovery.

Iconix provides reference systems and know-how to predict toxic liabilities and side effects of drug candidates and determine if they are on or off target.

Further Information: http://www.iconixpharm.com